Letters-repurpose
Latest
-
Consumers Have $1 Trillion More Savings Post-Pandemic: The Kiplinger Letter
The Kiplinger Letter GDP data show Americans have more savings than they did pre-pandemic.
By David Payne Published
The Kiplinger Letter -
After Weeks Without a Speaker, Congress Finally Returns to Legislating: The Kiplinger Letter
The Kiplinger Letter Major disagreements between and within Congress make it hard to reach compromises as Congress gets back to business
By Sean Lengell Published
The Kiplinger Letter -
Once-Booming Gun Sales Have Slumped
The Kiplinger Letter Since 2022, FBI background checks, a close proxy for gun purchases, have slumped.
By Sean Lengell Published
The Kiplinger Letter -
Biden Cracks Down on Child Labor: The Kiplinger Letter
The Kiplinger Letter The White House has announced steps to combat exploitative child labor in the U.S., which reached a two-decade high in 2023.
By Matthew Housiaux Published
The Kiplinger Letter -
GOP Lawmakers Demand SALT Deduction Cap Increase: Tax Letter
Tax Letter Republicans from high-tax states are clamoring for the SALT deduction cap to rise from its $10,000 limit.
By Joy Taylor Published
Tax Letter -
Democrats and Republicans Sidestep Tensions In Their Parties: The Kiplinger Letter
The Kiplinger Letter The country may be stuck with a closely divided House and a closely divided Senate for the foreseeable future.
By Sean Lengell Published
The Kiplinger Letter -
The Battle for Net Neutrality Rules Rages On: The Kiplinger Letter
The Kiplinger Letter Advocates remain hopeful new net neutrality rules will survive, while the telecom industry and business groups seek to prevent FCC action.
By John Miley Published
The Kiplinger Letter -
Autonomous Trucks Are Coming to a Road Near You: The Kiplinger Letter
The Kiplinger Letter What does the rollout of autonomous trucks and cars mean for the commercial sector?
By David Payne Published
The Kiplinger Letter -
Lawmakers Crackdown on Pharmacy Benefit Managers: The Kiplinger Letter
The Kiplinger Letter A crackdown on pharmacy benefit managers on drug costs might help Congress forget their differences.
By Matthew Housiaux Published
The Kiplinger Letter